Jefferies Group LLC Tg Therapeutics, Inc. Transaction History

Jefferies Group LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$6.27 - $8.65 $66,863 - $92,243	-10,664 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$4.02 - $8.04 $97,750 - $195,500	-24,316 Reduced 69.51%	10,664 $86,000
Q4 2018 Feb 14, 2019	BUY	$3.44 - $5.76 $56,347 - $94,348	16,380 Added 88.06%	34,980 $143,000
Q3 2018 Nov 14, 2018	BUY	$5.15 - $14.0 $71,070 - $193,200	13,800 Added 287.5%	18,600 $104,000
Q2 2018 Aug 14, 2018	BUY	$12.5 - $15.0 $60,000 - $72,000	4,800 New	4,800 $63,000

347

88M

2.35M

1.7M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.85B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.